Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL769262 | 0.77 | ADORA1 (0.45) | ADORA1 | |
| SCHEMBL5916326 | 0.71 | ADORA1 (0.38) | ADORA1 | |
| SCHEMBL783243 | 0.69 | LGALS8 (0.41) | ADORA1 | |
| SCHEMBL5245060 | 0.69 | ADORA1 (0.38) | ADORA1 | |
| SCHEMBL574712 | 0.69 | ADORA1 (0.39) | ADORA1 | |
| SCHEMBL263892 | 0.68 | ADORA1 (0.41) | ADORA1 | |
| SCHEMBL860142 | 0.67 | ADORA1 (0.37) | ADORA1 | |
| SCHEMBL29068760 | 0.67 | ADORA1 (0.41) | ADORA1 | |
| SCHEMBL94835 | 0.67 | PYGB (0.44) | — | |
| SCHEMBL27777686 | 0.67 | ADORA1 (0.37) | ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3688169-A2 | GENETIC KNOCKOUTS IN WOOD-LJUNGDAHL MICROORGANISMS | Lanzatech, Inc. (US) | 2020-08-05 | — | — | EP | disclosed |
| US-20200239896-A1 | GENETIC KNOCKOUTS IN WOOD-LJUNGDAHL MICROORGANISMS | LANZATECH, INC. | 2020-07-30 | — | — | US | disclosed |
| WO-2019068011-A2 | GENETIC KNOCKOUTS IN WOOD-LJUNGDAHL MICROORGANISMS | LANZATECH, INC. (US) | 2019-04-04 | — | — | WO | disclosed |
| US-20190040417-A1 | BIOLOGICAL FERMENTATION USING DIHYDROXYACETONE AS A SOURCE OF CARBON | KEMBIOTIX LLC (US) | 2019-02-07 | — | — | US | disclosed |
| WO-2017139420-A1 | BIOLOGICAL FERMENTATION USING DIHYDROXYACETONE AS A SOURCE OF CARBON | KEMBIOTIX LLC (US) | 2017-08-17 | — | — | WO | disclosed |
| US-20170037363-A1 | AMMONIA-OXIDIZING NITROSOMONAS EUTROPHA STRAIN D23 | AOBIOME LLC (US) | 2017-02-09 | — | — | US | disclosed |
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | BP CORP NORTH AMERICA INC (US) | 2015-08-27 | — | — | US | disclosed |
| US-8962800-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2015-02-24 | — | — | US | disclosed |
| US-20140242640-A1 | Methods of Making Nanotechnological and Macromolecular Biomimetic Structures | SUNGUROFF ALEXANDER (US) | 2014-08-28 | — | — | US | disclosed |
| US-20140017725-A1 | Methods of Making Nanotechnological and Macromolecular Biomimetic Structures | SUNGUROFF ALEXANDER (US) | 2014-01-16 | — | — | US | disclosed |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | VERENIUM CORPORATION (US) | 2010-01-14 | — | — | US | disclosed |
| US-20090275104-A1 | Bacillus licheniformis chromosone | NOVOZYMES A/S (DK) | 2009-11-05 | — | — | US | disclosed |
| US-7494798-B2 | Bacillus licheniformis chromosome | NOVOZYMES, INC. (US) | 2009-02-24 | — | — | US | disclosed |
| US-20080096253-A1 | Artificial ribosome for use as synthesis structure during in vitro translation | SUNGUROFF ALEXANDER | 2008-04-24 | — | — | US | disclosed |
| US-20080050774-A1 | Computer-based system for monitoring differential expression; host cells | NOVOZYMES A/S (DK) | 2008-02-28 | — | — | US | disclosed |
| CN-101082049-A | Corynebacterium glutamicum genes encoding metabolic pathway proteins | BASF AG (DE) | 2007-12-05 | — | — | CN | disclosed |
| CN-101074441-A | Corynebacterium glutamicum genes encoding metabolic pathway proteins | BASF AG (DE) | 2007-11-21 | — | — | CN | disclosed |
| US-20060252112-A1 | Methods for indentifying compounds that modulate an enzyme involved in biotin metabolism in a pathogenic microorganism | SCHECHTER ALAN M | 2006-11-09 | — | — | US | disclosed |
| US-20050260707-A1 | Corynebacterium glutamicum genes encoding metabolic pathway proteins | BASF AKTIENGESELLSCHAFT (DE) | 2005-11-24 | — | — | US | disclosed |
| WO-2002064794-A2 | HERBICIDE TARGET GENES AND METHODS | SYNGENTA PARTICIPATIONS AG (CH) | 2002-08-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150240226-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | POLN, POLM, POLI | ADORA1 1721/4885ADK 1513/4885 |
| US-20060252112-A1 | Methods for indentifying compounds that modulate an enzyme involved in biotin metabolism in a pathogenic microorganism | BTD, BLVRB, BPGM | ADORA1 2955/4885ADK 836/4885 |
| US-20100011456-A1 | Nucleic Acids and Proteins and Methods for Making and Using Them | POLN, POLM, POLI | ADORA1 1721/4885ADK 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.